Merck & Co Inc

NYSE: MRK
$99.85
-$1.17 (-1.2%)
Closing Price on January 8, 2025

MRK Articles

Exxon Mobil, Merck, Goldman Sachs, and Pfizer sink the DJIA on Thursday.
Oddly, perhaps, the best performing stock in the first two weeks of the year is drug maker Merck.
The the attacks against drug pricing and competition do not seem to be going away, but somehow, Merck has managed to find itself as a top pick for pharmaceutical and biohealth analysts.
The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through...
The the top analyst upgrades, downgrades and initiations on Thursday include AK Steel, Merck, Twitter, U.S. Steel, Walt Disney and Xerox.
Merck, Intel, IBM, Goldman Sachs lead Dow Jones Industrial Average higher Wednesday.
Biotech and pharma companies were on the move Wednesday. A few of the smaller caps made tremendous gains on the day, while a couple of the major firms saw massive volume and a slight move. Although...
The DJIA bull-bear projection of 21,422 would be short of the preliminary look of 22,000 seen at the end of December, but another 8.4% gain likely would be more than welcome.
There is an investment vehicle that may offer investors a way to stay in equities, get paid solid dividends and have the potential for outperforming total return.
Major Dow Jones Industrial Average companies in the health care sector saw a relatively strong 2016, with most posting a solid gain on the year.
A slimmer portfolio is expected to pay off for Procter & Gamble investors as the company now focuses on 10 product categories where it has about 65 category-leading brands.
ThinkstockJanuary 3, 2017: Markets opened higher Tuesday following the beginning of promised cuts to crude oil production by OPEC members and other nations as well as a strong report on manufacturing...
One strategy that has been quite common as investors rebalance and make changes each year is the Dogs of the Dow. Meet the 2017 Dogs of the Dow!
December 28, 2016: Markets opened higher Wednesday but any recovery from Tuesday’s end-of-day selling failed to materialize. Trading reversed course from Tuesday, where every S&P sector showed...
The December 15 short interest data have been compared with the previous figures, and short interest increased in most of these selected pharmaceutical stocks.
AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.